The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)anthracene-9,10-dione hydrochloride ID: ALA4471264
Cas Number: 2310262-11-2
PubChem CID: 146026197
Product Number: P647271, Order Now?
Max Phase: Preclinical
Molecular Formula: C22H20ClN3O2
Molecular Weight: 357.41
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cl.O=C1c2ccccc2C(=O)c2c1cccc2-c1cnn(C2CCNCC2)c1
Standard InChI: InChI=1S/C22H19N3O2.ClH/c26-21-17-4-1-2-5-18(17)22(27)20-16(6-3-7-19(20)21)14-12-24-25(13-14)15-8-10-23-11-9-15;/h1-7,12-13,15,23H,8-11H2;1H
Standard InChI Key: ZIMLKZKPNALXKK-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
11.6128 -19.9886 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
8.4635 -24.1360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4624 -24.9555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1704 -25.3645 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1686 -23.7271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8773 -24.1324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8761 -24.9530 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5823 -25.3621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5846 -23.7208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2953 -24.1344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2937 -24.9514 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9993 -25.3596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7070 -24.9519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7047 -24.1317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9985 -23.7272 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5846 -22.9036 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.5817 -26.1793 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.9966 -22.9101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6515 -22.4266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3974 -21.6497 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.5799 -21.6519 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.3293 -22.4297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8108 -20.9443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6284 -20.9508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0415 -20.2498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6411 -19.5371 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.8230 -19.5297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4053 -20.2352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 4 1 0
4 7 2 0
6 5 2 0
5 2 1 0
6 7 1 0
6 9 1 0
7 8 1 0
8 11 1 0
10 9 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
9 16 2 0
8 17 2 0
15 18 1 0
18 19 2 0
19 20 1 0
20 21 1 0
21 22 2 0
22 18 1 0
20 23 1 0
23 24 1 0
23 28 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 28 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 357.41Molecular Weight (Monoisotopic): 357.1477AlogP: 3.25#Rotatable Bonds: 2Polar Surface Area: 63.99Molecular Species: BASEHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 10.02CX LogP: 2.64CX LogD: 0.11Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.60Np Likeness Score: -0.18
References 1. Lee D, Pagire HS, Pagire SH, Bae EJ, Dighe M, Kim M, Lee KM, Jang YK, Jaladi AK, Jung KY, Yoo EK, Gim HE, Lee S, Choi WI, Chi YI, Song JS, Bae MA, Jeon YH, Lee GH, Liu KH, Lee T, Park S, Jeon JH, Lee IK, Ahn JH.. (2019) Discovery of Novel Pyruvate Dehydrogenase Kinase 4 Inhibitors for Potential Oral Treatment of Metabolic Diseases., 62 (2): [PMID:30623649 ] [10.1021/acs.jmedchem.8b01168 ]